PRAX Forex-Nachrichten
Praxis Precision Inks Licensing Deal With Tenacia Biotechnology For Ulixacaltamide In China
Biopharmaceutical company Praxis Precision Medicines, Inc. (PRAX) announced Friday an exclusive collaboration and license agreement with China-based clinical-stage biopharmaceutical company Tenacia Biotechnology (Shanghai) Company, Ltd.
RTTNews
|
vor 999 Tagen
